MX2016000195A - Oligosacaridos sinteticos para vacuna de p. aeruginosa. - Google Patents
Oligosacaridos sinteticos para vacuna de p. aeruginosa.Info
- Publication number
- MX2016000195A MX2016000195A MX2016000195A MX2016000195A MX2016000195A MX 2016000195 A MX2016000195 A MX 2016000195A MX 2016000195 A MX2016000195 A MX 2016000195A MX 2016000195 A MX2016000195 A MX 2016000195A MX 2016000195 A MX2016000195 A MX 2016000195A
- Authority
- MX
- Mexico
- Prior art keywords
- aeruginosa
- los
- synthetic oligosaccharides
- aeruginosa vaccine
- oligosaccharides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Gram-negative bacteria
- C07K16/1214—Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361842474P | 2013-07-03 | 2013-07-03 | |
| PCT/US2014/045057 WO2015002954A1 (en) | 2013-07-03 | 2014-07-01 | Synthetic oligosaccharides for p. aeruginosa vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016000195A true MX2016000195A (es) | 2016-08-18 |
Family
ID=52144159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016000195A MX2016000195A (es) | 2013-07-03 | 2014-07-01 | Oligosacaridos sinteticos para vacuna de p. aeruginosa. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20160144016A1 (enExample) |
| EP (1) | EP3016685B1 (enExample) |
| JP (1) | JP2016525507A (enExample) |
| KR (1) | KR20160098161A (enExample) |
| CN (1) | CN105517573A (enExample) |
| AU (1) | AU2014284457A1 (enExample) |
| CA (1) | CA2917192A1 (enExample) |
| CL (1) | CL2015003792A1 (enExample) |
| HK (1) | HK1217642A1 (enExample) |
| IL (1) | IL243432A0 (enExample) |
| MX (1) | MX2016000195A (enExample) |
| SG (1) | SG11201510792XA (enExample) |
| WO (1) | WO2015002954A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016138164A1 (en) * | 2015-02-26 | 2016-09-01 | Thevax Genetics Vaccine Co., Ltd. | A vaccine composition comprising an immunogenic protein and combination adjuvants for use in eliciting antigen-specific t-cell responses |
| CN107827981B (zh) * | 2017-11-01 | 2019-10-25 | 深圳市国创纳米抗体技术有限公司 | 抗绿脓杆菌外毒素a的纳米抗体及其应用 |
| CA3160266A1 (en) * | 2019-12-04 | 2021-06-10 | University Of Montana | Antibacterial carbohydrate vaccine |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4693891A (en) * | 1985-09-09 | 1987-09-15 | Miles Laboratories, Inc. | Vaccine for Pseudomonas aeruginosa |
| ATE458006T1 (de) * | 2003-05-14 | 2010-03-15 | Kenta Biotech Ag | Humaner monoklonaler antikörper spezifisch für lipopolysacchariden (lps) des serotyps iats o6 von pseudomonas aeruginosa |
| CN101912609B (zh) * | 2009-08-20 | 2012-02-01 | 成都蓉生药业有限责任公司 | 防治绿脓杆菌感染的组合物及其制备方法 |
| CA2797052A1 (en) * | 2010-04-23 | 2011-10-27 | Ancora Pharmaceuticals Inc. | Synthetic oligosaccharides for staphyloccocus vaccine |
| CN101947323B (zh) * | 2010-07-26 | 2013-02-27 | 北京绿竹生物制药有限公司 | 一种革兰氏阴性细菌疫苗及其制备方法 |
| WO2012082635A1 (en) * | 2010-12-13 | 2012-06-21 | Ancora Pharmaceuticals, Inc. | Synthetic oligosaccharide group a streptococcus |
| EP2554549A1 (en) * | 2011-08-02 | 2013-02-06 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools |
| EP2884842A4 (en) * | 2012-07-16 | 2016-04-20 | Visterra Inc | SYNTHETIC OLIGOSACCHARIDES FOR ANTI-P. aeruginosa |
-
2014
- 2014-07-01 SG SG11201510792XA patent/SG11201510792XA/en unknown
- 2014-07-01 WO PCT/US2014/045057 patent/WO2015002954A1/en not_active Ceased
- 2014-07-01 HK HK16105605.8A patent/HK1217642A1/zh unknown
- 2014-07-01 EP EP14820560.2A patent/EP3016685B1/en not_active Not-in-force
- 2014-07-01 CN CN201480048550.9A patent/CN105517573A/zh active Pending
- 2014-07-01 KR KR1020167001973A patent/KR20160098161A/ko not_active Withdrawn
- 2014-07-01 JP JP2016524315A patent/JP2016525507A/ja active Pending
- 2014-07-01 AU AU2014284457A patent/AU2014284457A1/en not_active Abandoned
- 2014-07-01 US US14/902,218 patent/US20160144016A1/en not_active Abandoned
- 2014-07-01 CA CA2917192A patent/CA2917192A1/en not_active Abandoned
- 2014-07-01 MX MX2016000195A patent/MX2016000195A/es unknown
-
2015
- 2015-12-30 CL CL2015003792A patent/CL2015003792A1/es unknown
- 2015-12-31 IL IL243432A patent/IL243432A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2917192A1 (en) | 2015-01-08 |
| AU2014284457A1 (en) | 2016-01-28 |
| HK1217642A1 (zh) | 2017-01-20 |
| SG11201510792XA (en) | 2016-01-28 |
| CL2015003792A1 (es) | 2017-01-20 |
| EP3016685A4 (en) | 2016-11-23 |
| KR20160098161A (ko) | 2016-08-18 |
| IL243432A0 (en) | 2016-03-31 |
| CN105517573A (zh) | 2016-04-20 |
| EP3016685B1 (en) | 2018-01-31 |
| US20160144016A1 (en) | 2016-05-26 |
| JP2016525507A (ja) | 2016-08-25 |
| WO2015002954A1 (en) | 2015-01-08 |
| EP3016685A1 (en) | 2016-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201903620B (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof | |
| MX2020001138A (es) | Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos. | |
| PH12015501000A1 (en) | Anti-notch3 antibodies and antibody-drug conjugates | |
| AU2018243910A8 (en) | A multiple antigen presenting system (MAPS)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof | |
| IN2015DN00694A (enExample) | ||
| MX371454B (es) | Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos. | |
| EA201991715A1 (ru) | Композиции, содержащие антитело к pdl1 | |
| BR112016025291A2 (pt) | conjugados de anticorpo anti-ptk7-fármaco | |
| MX2013010475A (es) | Composiciones inmunoterapeuticas de levadura-brachyuri. | |
| EA201791359A1 (ru) | Конъюгаты, связывающие белок-лекарственное средство, содержащие производные антрациклина | |
| EA201391602A1 (ru) | Контролируемое высвобождение иммунодепрессантов из синтетических наноносителей | |
| MX2015002482A (es) | Composicion inmunogenica. | |
| MX2013009252A (es) | Composiciones y procesos relacionados con los mismos plaguicidas. | |
| ZA201803476B (en) | Anti-cd22 antibody-maytansine conjugates and methods of use thereof | |
| TW201613641A (en) | Anti-CD22 antibody-drug conjugates and methods of using thereof | |
| WO2018053552A3 (en) | Isoquinolidinobenzodiazepines | |
| CL2012000744A1 (es) | Proceso para preparar un conjugado de polisacáridos capsulares tipo 5 o tipo 8 de s. aureus y una molécula transportadora; conjugado de polisacáridos; y composición inmunogénica que lo comprende. | |
| MX358829B (es) | Vacunas conjugadas de salmonela. | |
| AR095669A1 (es) | Toxinas, composiciones y métodos relacionados | |
| EA201592128A1 (ru) | Композиция против регургитации для поддерживания перистальтики кишечника | |
| UA116697C2 (uk) | Композиція для запобігання зараженню видами роду mycoplasma | |
| WO2016198170A8 (en) | Vaccines against streptococcus pneumoniae serotype 5 | |
| BR112015016033A8 (pt) | composições farmacêuticas para tratamento de infecções por bactérias, e seus usos | |
| CY1118277T1 (el) | Σταθερη φαρμακοτεχνικη μορφη πεξιγανανης | |
| MX2016002837A (es) | Una particula antimicrobiana y composiciones de la misma. |